Nevada law requires insulin firms to disclose prices and profits

The law – SB539
– also requires that suppliers provide the Department of Health and Human Services with information about the discounts they offer to third-party wholesalers.

Manufacturers are also required to justify and explain any price increases for insulin products above a certain level.

Companies that fail to disclose the information will face a $5,000 a day fine.

SB539_EN by Gareth Macdonald on Scribd

Go to Source